antibody drugs

locking horns fight battle lock horns
Favicon Fierce Pharma

GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement

Some four years into Jemperli’s commercial run, a rift has emerged between GSK unit Tesaro and the cancer drug's original developer, AnaptysBio.
Fraiser Kansteiner Nov 21, 2025 9:46am
HKEX

Leads Biolabs hits Hong Kong stock exchange in $189M IPO

Jul 25, 2025 10:59am
A chessboard with blocks that read MA

Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova

Jul 15, 2025 10:16am
Court lawsuit legal litigation

Biocon accused of IP theft to create cancer biotech Bicara

Oct 24, 2024 11:04am
An artists concept of different strains or types of coronaviruses shown in multiple bright colors against a teal background

AstraZeneca preps new COVID push after antibody's ph. 3 success

May 16, 2024 7:15am
Charles River

Charles River Labs partners with Wheeler Bio for CMC platform

Feb 26, 2024 3:15pm